Biotech Stock Roundup: BIIBs Acquisition, PTCT, LRMR Gain on Updates & More News
Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.…
75,520$
1,38%
Echtzeit-Aktienkurs PTC Therapeutics Inc.
Bid:
Ask:
Nachrichten zur PTC Therapeutics Inc. Aktie
PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna
…
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January…
PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
…
Earnings call: PTC Therapeutics reports strong first quarter financials By Investing.com
Earnings call: PTC Therapeutics reports strong first quarter financials…
PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
…
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for…
Earnings call: PTC Therapeutics reports strong growth and pipeline progress By Investing.com
Earnings call: PTC Therapeutics reports strong growth and pipeline progress…
PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript
…